ART4215
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for ART4215, covering 2026-01-27 to 2026-01-27. Get the full timeline:
Most recent: Clinical Trial Update: A Study of ART4215 for the Treatment of Advanced or Metastatic Solid Tumors [Phase 1]